DICE Therapeutics, Inc. Common Stock (DICE)

DICE was delisted on the 8th of August, 2023.

• Market cap: $2.27B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas.

Employees: 81